The incubation period of SARS-CoV-2 is rarely greater than 14 days. We report a patient with hypogammaglobulinemia who developed SARS-CoV-2 infection with a confirmed incubation period of at least 21 days. These findings raise concern for a prolonged presymptomatic transmission phase, necessitating a longer quarantine duration in this patient population.
Official Reporting for October 7, 2020
Cumulative Cases: 35,659,007
Cumulative Deaths: 1,044,269
Confirmed Cases: 35 848 254
Deaths: 1 048 181
Confirmed Cases: 36,026,644
Total cases: 7,475,262
Total deaths: 210,232
Montana: Hits new daily coronavirus record – Bozeman Daily Chronicle
Pennsylvania: New coronavirus cases and hospitalizations on rise in Pennsylvania, Lancaster County – Lancaster News
Wisconsin: Opening Field Hospital As Covid-19 Cases Surge – Forbes
Brazil: Tops 5 Million Cases – Bloomberg
New Zealand Stamps Out the Virus. For a Second Time – New York Times
UK: London Hit by Rising Coronavirus Infections – Bloomberg
UK: British Dorms on Lockdown After Coronavirus Outbreaks – New York Times
Science and Tech
FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic. FDA is issuing this guidance to provide sponsors of requests for Emergency Use Authorization (EUA) for COVID-19 vaccines with recommendations regarding the data and information needed to support the issuance of an EUA under section 564 of the FD&C Act (21 U.S.C. 360bbb-3) for an investigational vaccine to prevent COVID-19 for the duration of the COVID-19 public health emergency.
A large-scale research study that will facilitate at-home testing for both the SARS-CoV-2 virus and antibodies against it, is accepting applications from 10,000 current and former Brigham and Women’s Hospital patients.
Psychological and Sociological Impact
Several recent studies shed light on the pandemic preoccupations of sleepers. The swarm of insects — sometimes gnats, sometimes wasps or flying ants — arrived early in this year of nightmares. With summer came equally unsettling dreams: of being caught in a crowd, naked and mask-less; of meeting men in white lab coats who declared, “We dispose of the elders.”
A new report suggests that lingering “brain fog” and other neurological symptoms after COVID -19 recovery may be due to post-traumatic stress disorder (PTSD), an effect observed in past human coronavirus outbreaks such as SARS and MERS. People who have recovered from COVID-19 sometimes experience lingering difficulties in concentration, as well as headaches, anxiety, fatigue or sleep disruptions. Patients may fear that the infection has permanently damaged their brains, but researchers say that’s not necessarily the case.
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign – Clinical Microbiology and Infection
The Novel SARS-CoV-2 Pandemic: Possible Environmental Transmission, Detection, Persistence and Fate during Wastewater and Water Treatment – Science of the Total Environment
Misinformation, Disinformation, and Conspiracy Theories